Key facts
- Trigger: most often recent antibiotic use, which disrupts protective gut bacteria.
- What harms: toxins A and B — non-toxin-producing strains don’t cause disease.
- Testing nuance: detecting toxin genes can reflect carriage, not active infection.
- Recovery: the microbiome can take weeks–months to rebound; recurrence is common.
Clostridioides difficile (“C. diff”) is a spore-forming bacterium that causes antibiotic-associated diarrhea and colitis. It usually takes hold when antibiotics disrupt the protective colonic microbiome, letting C. difficile multiply and release toxins. The spores spread by the fecal-oral route and resist many disinfectants — which is why soap-and-water handwashing beats alcohol gel here.
Symptoms & who’s at risk
Typical symptoms are watery diarrhea (three or more loose stools a day), abdominal cramping, fever, nausea and loss of appetite. Severe disease can progress to pseudomembranous colitis and is a medical emergency. Risk is highest with recent or current antibiotics, healthcare or long-term-care exposure, age over 65, proton-pump inhibitors and a weakened immune system.
Why toxins A and B matter
Only toxin-producing strains cause disease. Toxin A and toxin B (encoded by the tcdA and tcdB genes) drive the inflammation and diarrhea; strains that don’t make these toxins don’t make people sick. This is the key to understanding the testing.
How C. diff is diagnosed — and why interpretation matters
Guidelines say to test only people with clinically significant, new, unexplained diarrhea — not asymptomatic people, and not as a “test of cure.” Labs combine methods because each answers a different question:
- GDH antigen: very sensitive but positive for toxin-producing and harmless strains — needs confirmation.
- Toxin A/B test: detects active toxin (specific for disease) but less sensitive.
- NAAT / PCR (toxin genes): very sensitive, but can be positive in people who merely carry the organism.
Because of this, IDSA/SHEA and ACG recommend a multi-step algorithm rather than one test alone. The same principle applies to comprehensive panels: the GI-MAP detects C. difficile toxin A and toxin B genes by qPCR, and a positive is interpreted by your practitioner alongside symptoms — gene detection is not proof of active infection, and the GI-MAP is not an emergency diagnostic.
Treatment (provider-directed)
Current guidelines have moved away from metronidazole as first-line. IDSA/SHEA now prefer fidaxomicin, with oral vancomycin an accepted alternative; metronidazole is reserved for when those aren’t available. Recurrent infection may be managed with tapered/pulsed vancomycin, fidaxomicin, the anti-toxin antibody bezlotoxumab, or fecal microbiota transplant (FMT) and newer FDA-approved microbiota therapies.
Recovery & recurrence
Symptoms often ease within days of the right antibiotic, but recurrence is common — and cumulative, so each episode raises the odds of another. The reason is the microbiome: C. diff both reflects and worsens a loss of “colonization resistance,” and diversity can take weeks to months to recover. That’s where the measure-adjust-remeasure approach fits — a follow-up GI-MAP can help a practitioner assess how the gut is rebuilding. See rebuilding your gut after an infection.
After C. diff, practitioners use a follow-up GI-MAP™ to assess microbiome recovery and gut-health markers.
Order Your GI-MAP™ Test → How it worksFrequently asked questions
What causes C. diff?
Most often recent antibiotics, which disrupt protective gut bacteria and let C. difficile multiply and release toxins.
How is C. diff diagnosed?
By stool testing in someone with new, unexplained diarrhea, using a multi-step approach because toxin-gene detection alone can reflect harmless carriage.
Does GI-MAP test for C. diff?
Yes — it detects toxin A and toxin B genes by qPCR, interpreted with symptoms by a practitioner. It is not an emergency diagnostic.
How long does recovery take?
Symptoms often improve within days on the right antibiotic, but the microbiome can take weeks to months to recover.
Why does C. diff keep coming back?
Because the protective microbiome is slow to recover; recurrence is common and each episode raises the risk of another.
Sources & further reading
- IDSA/SHEA — 2021 focused update, Clostridioides difficile guideline.
- CDC — C. difficile infection.
- Diagnostic Solutions Laboratory — GI-MAP test overview & methodology.